---
title: "Sotalol and Dental Care: QT Prolongation, Epinephrine Risks, and Chairside Precautions"
id: "dentistry-iq-0-sotalol-when-lol-is-no-laughing-matter"
canonical_url: "https://medichelpline.com/clinical-feed/dentistry-iq-0-sotalol-when-lol-is-no-laughing-matter"
content_type: "clinical_feed_article"
specialty: "Dentistry"
source_name: "DentistryIQ Clinical"
source_url: "https://www.dentistryiq.com/clinical/article/55407900/sotalol-and-dental-care-what-dental-professionals-need-to-know"
published_at: "2026-09-25T19:11:25.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Sotalol and Dental Care: QT Prolongation, Epinephrine Risks, and Chairside Precautions
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/dentistry-iq-0-sotalol-when-lol-is-no-laughing-matter
- **Specialty:** [Dentistry](https://medichelpline.com/clinical-feed/dentistry.md)
- **Primary Source:** DentistryIQ Clinical
- **Source URL:** [Original Journal Publication](https://www.dentistryiq.com/clinical/article/55407900/sotalol-and-dental-care-what-dental-professionals-need-to-know)
- **Published At:** 2026-09-25T19:11:25.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- Sotalol is a high-risk, hospital-initiated antiarrhythmic used for ventricular tachycardia and for maintaining sinus rhythm in symptomatic atrial fibrillation or flutter. It works by prolonging cardiac action potentials and the **QT interval**, which raises the risk of drug-induced arrhythmia. - Because of its narrow safety margin, sotalol must be started or restarted only in a hospital with at least three days of inpatient cardiac monitoring, continuous ECG, and resuscitation capability. This reflects its potential to provoke the very arrhythmias it is intended to prevent. - Sotalol is a **nonselective beta-blocker**, meaning it affects beta-1 and beta-2 receptors. Nonselective beta-blockade can leave epinephrine’s effects unopposed and may sharply raise blood pressure if epinephrine-containing local anesthetic is given without cardiology input. - Oral adverse effects associated with beta-blockers that are relevant to sotalol include xerostomia, taste disturbances, and lichenoid drug reactions that may mimic lichen planus; these require documentation, photography, and possible biopsy or referral. - Patients on sotalol commonly require coordination with cardiology or electrophysiology (EP) before any invasive dental procedure, and cardiology clearance should be obtained before surgery, sedation, or any plan involving epinephrine or potentially interacting medications. - The most dangerous dental-origin risk is prescribing medications that prolong the **QT interval** or interact with sotalol. Macrolide antibiotics (azithromycin, clarithromycin, erythromycin) are QT-prolonging and should be avoided; penicillin, amoxicillin, or cephalosporins are preferred when appropriate. Clindamycin and erythromycin are called out as drugs to avoid. - Many patients with atrial fibrillation/flutter are on **anticoagulants**; confirm anticoagulant use and coordinate timing for procedures with bleeding risk with the prescribing physician. - Most opioids combined with sotalol increase the risk of severe hypotension; hydrocodone and tramadol may also add QT prolongation and syncope risk. Discuss analgesic choices with the cardiologist. - Practical chairside steps include confirming the medication list, obtaining cardiology/EP clearance before invasive care, recording baseline vitals, treating epinephrine use as a cardiology decision, avoiding macrolides, asking about anticoagulants, and keeping emergency equipment available. - The central takeaway: sotalol is not a routine antihypertensive. It is a hospital-initiated, QT-sensitive antiarrhythmic with a narrow therapeutic margin; one phone call to cardiology can prevent serious complications after dental care.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.dentistryiq.com/clinical/article/55407900/sotalol-and-dental-care-what-dental-professionals-need-to-know#content) [](https://www.dentistryiq.com/search) [![Dentistry IQ header logo](https://img.dentistryiq.com/files/base/ebm/diq/image/website/logos/1651156415077-logo.png?height=55)](https://www.dentistryiq.com/) Modern dentistry done smarter * [Newsworthy](https://www.dentistryiq.com/newsworthy) * [Clinical](https://www.dentistryiq.com/clinical) * [Business Management & Leadership](https://www.dentistryiq.com/business-management-leadership) * [Revenue Cycle Management](https://www.dentistryiq.com/revenue-cycle-management) [![Dentistry IQ mega menu logo](https://img.dentistryiq.com/files/base/ebm/diq/image/website/logos/1752510663448-dentistryiq_finallogo_white_reg.png?auto=format,compress&height=45)](https://www.dentistryiq.com/) Sections [Newsworthy](https://www.dentistryiq.com/newsworthy) [Clinical](https://www.dentistryiq.com/clinical) [Business Management & Leadership](https://www.dentistryiq.com/business-management-leadership) [Revenue Cycle Management](https://www.dentistryiq.com/revenue-cycle-management) Special [Advisory Board](https://www.dentistryiq.com/EditorialAdvisoryBoard) [Continuing Education](https://dentalacademyofce.com) [Videos](https://www.dentistryiq.com/videos) [Front Office Forms](https://www.dentistryiq.com/front-office/office-forms) [Free Samples](https://www.dentistryiq.com/free-samples) [Innovator Awards](https://dental.endeavorb2b.com/dental-innovator-awards) [White Papers](https://www.dentistryiq.com/white-papers) Contact [About Us](https://www.dentistryiq.com/about-us) [Advertise](https://dental.endeavorb2b.com/dentistry-iq/) [Contact Us](https://www.dentistryiq.com/contact-us) [Newsletters](https://www.dentistryiq.com/dental-group-newsletter-info) [Newsletter Subscription](https://endeavor.dragonforms.com/loading.do?omedasite=DECnewpref&pk=DEC_MENU) [Submission Guidelines](https://www.dentistryiq.com/submission-guidelines) Affiliated Brands [RDH UNDER ONE ROOF](https://www.rdhunderoneroof.com/rdhuor2025) [DENTAL ECONOMICS](https://www.dentaleconomics.com) [PERIO-IMPLANT ADVISORY](https://www.perioimplantadvisory.com) [RDH](https://www.rdhmag.com) Follow us on [ ](https://www.facebook.com/DentistryIQ) [ ](https://www.instagram.com/dentistry___iq/) [ ](https://www.linkedin.com/company/dentistryiq/) [ ](https://twitter.com/DentistryIQ) [ ](https://www.youtube.com/channel/UCm8U6hZE-uCLCEx_MSs7fpw) [Clinical](https://www.dentistryiq.com/clinical) # Sotalol: When “LOL” is no laughing matter Sotalol can present important dental treatment risks, from QT prolongation and drug interactions to concerns with epinephrine and anticoagulants. Review key chairside considerations for safely treating patients taking this high-risk antiarrhythmic. [Lisa Chan, DDS](https://www.dentistryiq.com/55233646) Sept. 25, 2026 8 min read [ Add Us On Google ](https://www.google.com/preferences/source?q=dentistryiq.com) * [](javascript:void\(0\)) * [](javascript:void\(0\)) * [](javascript:void\(0\)) * [](javascript:void\(0\)) * [](https://www.dentistryiq.com/print/content/55407900) ## Key Highlights * Sotalol is a high-risk antiarrhythmic with QT-prolonging effects that require careful dental treatment planning. * Coordinate with cardiology before invasive procedures and carefully evaluate epinephrine, anticoagulants, and other medications. * Watch for oral effects such as xerostomia, taste changes, and lichenoid drug reactions in patients taking sotalol. Bacsica/iStock-Getty Images Plus ![a 3D rendering of a sotalol molecule](https://img.dentistryiq.com/files/base/ebm/diq/image/2026/09/6ab6c62e962252ba5ed0dd3a-website_thumbnail.png?auto=format,compress&fit=fill&fill=blur&q=45?w=250&width=250)a 3D rendering of a sotalol molecule I was recently talking with a patient who happens to be a subspecialty cardiology pharmacist. I mentioned [an article I'd written about amiodarone](https://www.dentistryiq.com/dentistry/pharmacology/article/55352322/pause-before-you-proceed-why-amiodarone-should-stop-every-dentist-in-their-tracks), and she stopped me mid-sentence: "I hope you're writing about sotalol next." This medication is just as much a red flag as amiodarone; the difference is that sotalol is used for V-tach (ventricular tachycardia).1 V-tach, is a dangerously fast heart rhythm that keeps the heart from filling with blood properly, starving the body and brain of oxygen. Left untreated, V-tach can degrade into ventricular fibrillation, a chaotic rhythm in which the heart stops pumping blood altogether. Sotalol is also prescribed for atrial fibrillation, atrial flutter, and other rhythm disorders, so the warning reaches well beyond the V-tach population alone. I admitted to the pharmacist that when I see “lol” at the end of a medication name, I immediately think it is a beta-blocker for hypertension. Sotalol is a good reminder of why that kind of shorthand can get us into trouble. It is also exactly the type of medication that reinforced for me why we built MedAssent DDS. Dental providers should not have to recognize every drug name from memory or dig through pages of pharmacology to figure out what matters chairside. A quick medication check should surface the dental implications, prescribing concerns, and interactions that actually affect the treatment decision. With sotalol, there is quite a bit to surface. ## Sotalol is a lone wolf According to its own prescribing information,2 sotalol isn't approved for hypertension at all. It's indicated for documented, life-threatening ventricular arrhythmias and for maintaining sinus rhythm in patients with highly symptomatic atrial fibrillation or flutter.3 The "lol" in its name is almost incidental in this conversation. What should really grab your attention is that sotalol works by prolonging cardiac action potentials and the QT interval. I bring up the QT interval because a surprising number of medications affect it, and a dentist should think twice before prescribing anything that does. ## Started in a hospital bed, not picked up at the pharmacy Sotalol comes with a requirement that tells you everything you need to know about its risk profile: it cannot legally be started, or restarted after any interruption, outside a hospital. FDA labeling for Sotalol2 calls for a minimum of three days of inpatient cardiac monitoring, continuous ECG, and resuscitation capability before a patient ever takes a dose outside that setting. Sotalol has a close cousin you may also see on a patient's medication list: dofetilide (Tikosyn),4 which carries the same hospital-initiation requirement. That level of caution exists because the very arrhythmia the drug is meant to prevent can also be a side effect of the drug itself. A patient on sotalol isn't a stable hypertensive; they're under active electrophysiology management on a drug with a narrow safety margin, and that should recalibrate how your team approaches the appointment. Get cardiac clearance before any dental procedure, end of story. And most definitely, don't reach for a local anesthetic with epinephrine without checking first. Sotalol is nonselective, and nonselective beta-blockers can leave epinephrine’s effects unopposed,5 which can drive blood pressure up sharply. What do I mean by "nonselective"? _Beta-blockers are classified as selective or nonselective, and, just to keep things interesting, also by generation._ **There are three types of beta-blockers 6:** * Cardioselective beta-blockers, such as metoprolol (Lopressor, Toprol XL), atenolol (Tenormin), bisoprolol, and nebivolol (Bystolic), act mainly on beta-1 receptors in heart muscle, which is why they are a popular medication for hypertension, rate control, and heart failure. * Nonselective beta-blockers, including propranolol (Inderal) and nadolol, reach beyond the heart to beta-2 receptors in the lungs and blood vessels as well. Sotalol sits in that nonselective column,7 but the resemblance to your average blood-pressure medication ends about there. * There are also combined alpha- and beta-blockers, such as carvedilol (Coreg) and labetalol (Normodyne, Trandate). These promote blood vessel relaxation (vasodilation), which is linked to lower rates of fatigue and sexual dysfunction than older beta-blockers. ## What you might see in the mouth Sotalol's nonselective beta-blockade carries the same oral side-effect profile common to that whole drug class. Xerostomia is among the most frequently reported complaints8 in patients on beta-blockers, and it deserves the usual response: a caries risk assessment, salivary substitutes, a fluoride supplement if indicated, and closer recall intervals. Taste disturbance, including a blunted or distorted sense of taste, has also been reported with beta-blocker therapy9 and is worth asking about directly rather than waiting for a patient to bring it up. Beta-blockers as a class are recognized triggers for oral lichenoid drug reactions10: white, reticular, or erosive lesions that closely mimic ordinary lichen planus. These lesions can surface months after the medication was started, so the connection is easy to miss unless you're actively checking the medication history against the timeline of a new lesion. Any suspicious finding in a patient on sotalol deserves photography, documentation, and a biopsy or referral. ## The cardiology call comes first A patient on sotalol has, by definition, already been hospitalized once just to start the medication. That fact alone should prompt a call to the cardiologist or EP (electrophysiology) specialist before you finalize any treatment plan, not only before surgery or sedation. Ask whether any antibiotic or analgesic you're considering is contraindicated, and whether epinephrine in local anesthetics or retraction cord should be avoided. It's also worth remembering that many patients managed for atrial fibrillation or flutter are also prescribed an anticoagulant11 to lower stroke risk. That matters the moment you're planning an extraction or any procedure with bleeding potential. It’s easier to coordinate timing with the physician rather than assuming. ## The prescription pad is where this gets dangerous The most consequential risk a dentist can introduce is the prescription written at the end of the appointment. Macrolide antibiotics deserve equal caution with sotalol and not for renal reasons. Macrolide antibiotics such as azithromycin (Zithromax),12 clarithromycin (Biaxin), and Erythromycin (EES or Ery tab) are independently recognized as QT-prolonging agents.13 Stacking a QT-prolonging antibiotic on top of sotalol can be a dangerous game. Run any medication you are considering prescribing through a drug interaction checker like [MedAssent DDS](https://www.medassentdds.com/), or have the front office do it, even if you're running behind schedule. It takes a minute. Cover your tail and keep the patient safe. Most opioids in combination with sotalol raise the risk of severe hypotension, and hydrocodone and tramadol can also add QT prolongation and syncope to that risk. Speak with the cardiologist before prescribing or recommending anything for post-op pain. For most dental infections, the safer path is penicillin or amoxicillin, moving to Augmentin for something more advanced, and doxycycline for a penicillin-allergic patient. Avoid erythromycin and clindamycin. But the final call should still be made together with the patient's cardiologist. A five-minute phone call before you send the prescription can prevent an emergency room visit, or worse. ## Your chairside checklist * Confirm the complete medication list; ask to see the patient's medication app or patient portal if memory is questionable. * Obtain clearance from cardiology or the EP (electrophysiology) cardiology subspecialist before any invasive procedure. * Record baseline blood pressure and heart rate. * Treat epinephrine as a decision for the cardiologist, not a default. * Avoid macrolide antibiotics; choose penicillin, amoxicillin, or a cephalosporin instead (unless the patient is allergic to penicillin). * Ask about anticoagulant use before any procedure with bleeding risk. * Keep emergency equipment within reach. ## The takeaway I thanked my patient for the conversation, and I meant it. Her point is worth repeating to every dentist and hygienist reading this: a drug name is not a diagnosis, and a familiar-looking suffix can be the most dangerous kind of camouflage. Sotalol is not a garden-variety antihypertensive. It's a hospital-initiated, QT-sensitive, narrow-margin antiarrhythmic prescribed to patients whose hearts have already shown they can go seriously wrong. Reviewing the medical history and making one phone call to the cardiologist is a small price for keeping that patient safely out of the emergency department or worse. **Also by the author:** * [My patient needed a fecal transplant after a dental infection](https://www.dentistryiq.com/dentistry/oral-systemic-health/article/55365324/my-patient-needed-a-fecal-transplant-after-a-dental-infection) * [Five drugs that instantly tell me a patient has dementia](https://www.dentistryiq.com/clinical/article/55386479/five-drugs-that-instantly-tell-me-a-patient-has-dementia) ### References 1. Lovik K, Ahmed I. _Ventricular Tachycardia_. StatPearls Publishing; 2026. 2. Label: Betapace–sotalol hydrochloride tablet. DailyMed. National Library of Medicine. 3. Mubarik A, Patel P, Cassagnol M. _Sotalol_. StatPearls Publishing; 2024. 4. Tikosyn dosage and administration. Pfizer Medical. 5. Reeves RA, Boer WH, DeLeve L, Leenen FH. [Nonselective beta-blockade enhances pressor responsiveness to epinephrine, norepinephrine, and angiotensin II in normal man](https://pubmed.ncbi.nlm.nih.gov/6705443/). _Clin Pharmacol Ther_. 1984;35(4)):461-466. doi:10.1038/clpt.1984.60 6. Beta-blockers. Cleveland Clinic. Updated April 17, 2025. 7. Farzam K, Jan A. _Beta Blockers_. StatPearls Publishing; 2023. 8. Nederfors T. [Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists](https://pubmed.ncbi.nlm.nih.gov/8813731/). _Swed Dent J Suppl_. 1996;116:1-70. 9. Rademacher WMH, Aziz Y, Hielema A, et al. [Oral adverse effects of drugs: taste disorders](https://pubmed.ncbi.nlm.nih.gov/31532870/). _Oral Dis_. 2020;26(1):213-223. doi:10.1111/odi.13199 10. Fessa C, Lim P, Kossard S, Richards S, Fernandez Peñas P. [Lichen planus-like drug eruptions due to β-blockers: a case report and literature review](https://pubmed.ncbi.nlm.nih.gov/22809321/). _Am J Clin Dermatol_. 2012;13(6):417-421. doi:10.2165/11634590-000000000-00000 11. Atrial fibrillation. Mayo Clinic. 12. Label: Zithromax–azithromycin tablet, film coated. DailyMed. National Library of Medicine. 13. Iqbal F, Derouen A, Ren R, et al. [Macrolide antibiotic mediated cardiac arrhythmias: emerging concepts and clinical implications](https://pubmed.ncbi.nlm.nih.gov/40564197/). _Biomedicines_. 2025;13(6):1478. doi:10.3390/biomedicines13061478 ## About the Author ![Lisa Chan, DDS](https://img.dentistryiq.com/files/base/ebm/diq/image/2024/10/670409625587e885d306587a-lisa_chan_dds.png?w=120&h=120&fit=crop)Lisa Chan, DDS ### [Lisa Chan, DDS](https://www.dentistryiq.com/resources/contact/55233646/lisa-chan-dds) **Lisa Chan, DDS,** is chief executive officer and cofounder of [MedAssent DDS](https://www.medassentdds.com/). She has more than 35 years of dentistry experience, including roles as a hospital dentist at Kaiser Permanente, a private practitioner, and a California State Dental Board consultant. With a DDS from USC, she focuses on promoting equity and integrated care anad addressing challenges in patient safety. Dr. Chan serves on educational and community boards, including Santa Monica College, UC San Diego, Los Angeles FBI, and the Salvation Army. Sign up for our eNewsletters Get the latest news and updates Sign Up # Related [![Want a $2 million practice? Start thinking smaller](https://informa.blueconic.net/rest/v2/contentStores/6d95b98e-ca7f-49e2-bf12-8862157adfdf/items/55405260/image?auto=format,compress&fit=crop&q=45&h=139&height=139&w=250&width=250)Want a $2 million practice? Start thinking smaller ](https://informa.blueconic.net/rest/v2/recommendations/redirect?storeId=6d95b98e-ca7f-49e2-bf12-8862157adfdf&profileId=&itemId=55405260) ## [Want a $2 million practice? Start thinking smaller](https://informa.blueconic.net/rest/v2/recommendations/redirect?storeId=6d95b98e-ca7f-49e2-bf12-8862157adfdf&profileId=&itemId=55405260) [![The danger of zinc in denture adhesives](https://informa.blueconic.net/rest/v2/contentStores/6d95b98e-ca7f-49e2-bf12-8862157adfdf/items/55360428/image?auto=format,compress&fit=crop&q=45&h=139&height=139&w=250&width=250)The danger of zinc in denture adhesives ](https://informa.blueconic.net/rest/v2/recommendations/redirect?storeId=6d95b98e-ca7f-49e2-bf12-8862157adfdf&profileId=&itemId=55360428) ## [The danger of zinc in denture adhesives](https://informa.blueconic.net/rest/v2/recommendations/redirect?storeId=6d95b98e-ca7f-49e2-bf12-8862157adfdf&profileId=&itemId=55360428) # Trending ## [Pyogenic granuloma: What is it, and how do you help your patients who have it?](https://informa.blueconic.net/rest/v2/recommendations/redirect?storeId=6d95b98e-ca7f-49e2-bf12-8862157adfdf&profileId=&itemId=14209442) ## [Dental anxiety: Why “just relax” is not enough in the dental chair](https://informa.blueconic.net/rest/v2/recommendations/redirect?storeId=6d95b98e-ca7f-49e2-bf12-8862157adfdf&profileId=&itemId=55406675) ## [Clinical interest in stem cell-based therapy for bone regeneration rising: New JADA study](https://informa.blueconic.net/rest/v2/recommendations/redirect?storeId=6d95b98e-ca7f-49e2-bf12-8862157adfdf&profileId=&itemId=55405919) Load More Content [![footer logo Dentistry IQ](https://img.dentistryiq.com/files/base/ebm/diq/image/website/logos/1651156415077-logo.png?height=45)footer logo Dentistry IQ](https://www.dentistryiq.com/) DentistryIQ delivers timely dental news, expert analysis, and industry intelligence for professionals across the dental industry - reflecting the full scope of modern dentistry. Newsletters The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox. Sign Up Connect Follow us for the latest industry news and insights. [ ](https://www.facebook.com/DentistryIQ) [ ](https://www.instagram.com/dentistry___iq/) [ ](https://www.linkedin.com/company/dentistryiq/) [ ](https://twitter.com/DentistryIQ) [ ](https://www.youtube.com/channel/UCm8U6hZE-uCLCEx_MSs7fpw) Affiliated Brands [RDH UNDER ONE ROOF](https://www.rdhunderoneroof.com/rdhuor2025) [DENTAL ECONOMICS](https://www.dentaleconomics.com) [PERIO-IMPLANT ADVISORY](https://www.perioimplantadvisory.com) [RDH](https://www.rdhmag.com) * [About Us](https://www.dentistryiq.com/about-u
## Related Clinical Research

- [Post-stroke recrudescence vs new stroke: distinguishing features, causes, investigations, and mana](https://medichelpline.com/clinical-feed/cmaj-2-a-58-year-old-patient-with-right-sided-weakness-and-a-history-of-stroke-practice.md)
- [Alzheimer’s Biomarkers in Dental Practice: Risks, Limitations, and Practical Alternatives](https://medichelpline.com/clinical-feed/dentistry-iq-14-alzheimer-s-biomarkers-in-dental-practice-is-innovation-outpacing-readiness.md)
- [Sick leave patterns after transient ischemic attack (TIA) in working-age adults: a Swedish registe](https://medichelpline.com/clinical-feed/plos-one-3-sick-leave-after-transient-ischemic-attack-among-working-age-adults-in-sweden-a.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Patient Knowledge of Anticoagulant Use in Atrial Fibrillation: Cross-Sectional Survey Results](https://medichelpline.com/clinical-feed/pubmed-42788824.md) (DOI: 10.5543/tkda.2026.23942)

## Navigation
- [← Back to Dentistry Feed](https://medichelpline.com/clinical-feed/dentistry.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.